MedAdvisor new deal with EBOS’s Zest | Finance News Network

MedAdvisor new deal with EBOS’s Zest

Company News

by Rachael Jones

MedAdvisor (ASX:MDR) Australia’s leading digital medication management company, is pleased to announce it has formalised its agreement with EBOS subsidiary Zest, following EBOS Group’s investment in MedAdvisor back in October last year.

Under the agreement, MedAdvisor will provide a digital communication channel for Zest’s healthcare programs, enabling better connections with manufacturers and the community.

This partnership may extend further as the Company’s hospital market expansion strategy rolls out, through collaboration on tailored and customised hospital discharge programs. outcomes.

Shares in MedAdvisor (ASX: MDR) are trading flat at 4.2c.
 

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.